CSII Versus MDI in Pregnant Women With Type 2 Diabetes

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The primary objective of the study is to determine if continuous subcutaneous insulin infusion (CSII) can improve glycemic control in women with type 2 diabetes (T2D) who are pregnant.
Epistemonikos ID: 5784b49249914bb49eb9173bb49cc66cd72785d1
First added on: Jul 25, 2023